3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Colorectal Neoplasms
12
Pancreatic Neoplasms
7
Nasopharyngeal Carcinoma
5
Cholangiocarcinoma
5
Biliary Tract Neoplasms
4
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Cirrhosis, Familial, with Pulmonary Hypertension
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Urinary Bladder Neoplasms
1
Rare Tumour
1
Pathologic Complete Response
1
Pancreatic Cancer Resectable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Neoplasm, Residual
1
Neoadjuvant Chemotherapy
1
Muscle Neoplasms
1
Locally Advanced Low Rectal Adenocarcinoma
1
Liver Neoplasms
1
Liver Metastases of Colorectal Cancer
1
Keratosis, Actinic
1
HER2-positive Gastric Cancer
1
Gastroesophageal Junction Cancer
1
Interventions
Tamoxifen
1
Melphalan
1
Fluorouracil
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Muscle Neoplasms
×
Fluorouracil
×
Clear all
NCT06154590
2023-12-04
NASBP-B-09
Paradyne Networks A Foundation
Not yet recruiting
100 enrolled